Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Editorial

Nephrolithiasis: nutrition as cause or therapeutic tool

Authors: Irene Brenna, Elena Dogliotti, Annalisa Terranegra, Benedetta Raspini, Laura Soldati

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Nephrolithiasis is a very common disease with an increasing prevalence among industrialized populations. Kidney stone formation is a complex phenomenon, involving genetic and metabolic patterns, and nutrition can play an important role in this match both as a promoter or as a protective factor. To promote a deeper knowledge of such a challenging disease, clinicians and researchers have met in Rome, Italy, last March 2013, at the International Congress “Nephrolithiasis: a systemic disorder” to discuss patho-physiology and possible treatment of kidney stones. During the meeting, a whole session was dedicated to nutrition, seen both as a cause or a therapeutic tool for nephrolithiasis. Due to its etiopathogenesis, nephrolithiasis is also an ideal model for a nutrigenetics and nutrigenomics approach. Nutrigenomics and nutrigenetic respectively study the effects of a dietary treatment on gene expression and, on the other hand, the impact of an inherited trait on the response to a specific dietary treatment.
Literature
1.
go back to reference Bartoletti R, Cai T, Mondaini N, Melone F, Travaglini F, Carini M, Rizzo M: Epidemiology and risk factors in urolithiasis. Urol Int. 2007, 79: 3-7. 10.1159/000104434.CrossRefPubMed Bartoletti R, Cai T, Mondaini N, Melone F, Travaglini F, Carini M, Rizzo M: Epidemiology and risk factors in urolithiasis. Urol Int. 2007, 79: 3-7. 10.1159/000104434.CrossRefPubMed
2.
go back to reference Arcidiacono T, Terranegra A, Biasion R, Soldati L, Vezzoli G: Calcium kidney stones: diagnostic and preventive prospects. G Ital Nefrol. 2007, 24 (6): 535-546.PubMed Arcidiacono T, Terranegra A, Biasion R, Soldati L, Vezzoli G: Calcium kidney stones: diagnostic and preventive prospects. G Ital Nefrol. 2007, 24 (6): 535-546.PubMed
4.
go back to reference Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incident kidney stones in younger women (Nurses’ Health Study II). Arch Intern Med. 2004, 164: 885-891. 10.1001/archinte.164.8.885.CrossRefPubMed Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incident kidney stones in younger women (Nurses’ Health Study II). Arch Intern Med. 2004, 164: 885-891. 10.1001/archinte.164.8.885.CrossRefPubMed
5.
go back to reference West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H: Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008, 51: 741-747. 10.1053/j.ajkd.2007.12.030.CrossRefPubMed West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H: Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008, 51: 741-747. 10.1053/j.ajkd.2007.12.030.CrossRefPubMed
6.
go back to reference Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R: The effect of high animal protein intake on the risk of calcium-stone formation in the urinary tract. Clin Sci. 1979, 57: 285-288.CrossRefPubMed Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R: The effect of high animal protein intake on the risk of calcium-stone formation in the urinary tract. Clin Sci. 1979, 57: 285-288.CrossRefPubMed
7.
go back to reference Taylor EN, Stampfer MJ, Curhan GC: Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow up. J Am Soc Nephrol. 2004, 15 (12): 3225-3232. 10.1097/01.ASN.0000146012.44570.20.CrossRefPubMed Taylor EN, Stampfer MJ, Curhan GC: Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow up. J Am Soc Nephrol. 2004, 15 (12): 3225-3232. 10.1097/01.ASN.0000146012.44570.20.CrossRefPubMed
8.
go back to reference Taylor EN, Curhan GC: Fructose consumption and the risk of kidney stones. Kidney Int. 2008, 73 (2): 207-212. 10.1038/sj.ki.5002588.CrossRefPubMed Taylor EN, Curhan GC: Fructose consumption and the risk of kidney stones. Kidney Int. 2008, 73 (2): 207-212. 10.1038/sj.ki.5002588.CrossRefPubMed
9.
go back to reference Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F: The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004, 66: 2402-2410. 10.1111/j.1523-1755.2004.66029.x.CrossRefPubMed Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F: The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004, 66: 2402-2410. 10.1111/j.1523-1755.2004.66029.x.CrossRefPubMed
10.
go back to reference Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91 (3): 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91 (3): 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed
11.
go back to reference Vezzoli G, Terranegra A, Soldati L: Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr Opin Nephrol Hypertens. 2012, 21 (4): 355-361. 10.1097/MNH.0b013e3283542290.CrossRefPubMed Vezzoli G, Terranegra A, Soldati L: Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr Opin Nephrol Hypertens. 2012, 21 (4): 355-361. 10.1097/MNH.0b013e3283542290.CrossRefPubMed
12.
go back to reference Falchetti A, Gozzini A, Terranegra A, Soldati L, Vezzoli G, Leoncini G, Giusti F, Franceschelli F, Masi L, Tanini A, Cavalli L, Brandi ML: A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Eur J Endocrinol. 2012, 166 (5): 933-940. 10.1530/EJE-11-0953.CrossRefPubMed Falchetti A, Gozzini A, Terranegra A, Soldati L, Vezzoli G, Leoncini G, Giusti F, Franceschelli F, Masi L, Tanini A, Cavalli L, Brandi ML: A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Eur J Endocrinol. 2012, 166 (5): 933-940. 10.1530/EJE-11-0953.CrossRefPubMed
13.
go back to reference Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L: R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007, 71 (11): 1155-1162. 10.1038/sj.ki.5002156.CrossRefPubMed Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L: R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007, 71 (11): 1155-1162. 10.1038/sj.ki.5002156.CrossRefPubMed
14.
go back to reference Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J: Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J. 2012, 31 (8): 1999-2012. 10.1038/emboj.2012.49.PubMedCentralCrossRefPubMed Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J: Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J. 2012, 31 (8): 1999-2012. 10.1038/emboj.2012.49.PubMedCentralCrossRefPubMed
15.
go back to reference Moe OW: Uric acid nephrolithiasis: proton titration of an essential molecule?. Curr Opin Nephrol Hypertens. 2006, 15 (4): 366-373. 10.1097/01.mnh.0000232876.04975.33.CrossRefPubMed Moe OW: Uric acid nephrolithiasis: proton titration of an essential molecule?. Curr Opin Nephrol Hypertens. 2006, 15 (4): 366-373. 10.1097/01.mnh.0000232876.04975.33.CrossRefPubMed
16.
go back to reference Maalouf NM, Cameron MA, Moe OW, Sakhaee K: Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol. 2010, 5 (7): 1277-1281. 10.2215/CJN.08331109.PubMedCentralCrossRefPubMed Maalouf NM, Cameron MA, Moe OW, Sakhaee K: Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol. 2010, 5 (7): 1277-1281. 10.2215/CJN.08331109.PubMedCentralCrossRefPubMed
Metadata
Title
Nephrolithiasis: nutrition as cause or therapeutic tool
Authors
Irene Brenna
Elena Dogliotti
Annalisa Terranegra
Benedetta Raspini
Laura Soldati
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-178

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.